Because the marker of astrocyte activity is the GFAP gene, an increase in GFAP is associated with an increase in astrocyte activity, so by these results, prolactin may have exerted its protective effects on the improvement of movement disorders by acting on astrocytes in the affected regions. This evidence concerns the gene PRL and movement disorder.